isoproterenol has been researched along with visnagin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Abukhalil, MH; Al-Amarat, W; Al-Swailmi, FK; Aladaileh, SH; Alanazi, KM; Alfwuaires, MA; Algefare, AI; Althunibat, OY; Hussein, OE; Kamel, EM; Mahmoud, AM; Saghir, SA | 1 |
1 other study(ies) available for isoproterenol and visnagin
Article | Year |
---|---|
Visnagin prevents isoproterenol-induced myocardial injury by attenuating oxidative stress and inflammation and upregulating Nrf2 signaling in rats.
Topics: Adrenergic beta-Agonists; Animals; Inflammation; Isoproterenol; Khellin; Male; Myocardial Infarction; NF-E2-Related Factor 2; Oxidative Stress; Rats; Rats, Wistar; Signal Transduction; Up-Regulation | 2021 |